Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

632.41 -16.32 (-2.52%)
Streaming Delayed Price Updated: 12:36 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024. 
Via MarketBeat
News headline image
2 Top Healthcare Stocks to Buy Right Now ↗
One has a breakout drug, the other a nice-sized moat. 
Via The Motley Fool
News headline image
2 Top Stocks I'm Buying Hand Over Fist in February ↗
Despite underwhelming earnings reports, these businesses remain great investments in 2023. 
Via The Motley Fool
News headline image
Where IDEXX Laboratories Stands With Analysts ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Analyst Says IDEXX Laboratories' Long-Term Growth Outlook Remains Strong ↗
 
Via Benzinga
News headline image
A Preview Of IDEXX Laboratories's Earnings ↗
 
Via Benzinga
News headline image
Golden Cross Appears Before IDEXX Laboratories Investors ↗
 
Via Benzinga
Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Why IDEXX Stock Popped Today ↗
The animal healthcare company beat estimates on the top and bottom lines. 
Via The Motley Fool
News headline image
Earnings Scheduled For February 6, 2023 ↗
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. 
Via Benzinga
News headline image
Five Best And Worst Performing Healthcare Stocks In January 2023 ↗
After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the sector. Let’s take a look at the five best and... 
Via Talk Markets
News headline image
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark ↗
On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier. 
Via Investor's Business Daily
News headline image
Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge ↗
The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps. 
Via Investor's Business Daily
News headline image
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers ↗
The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better. 
Via Investor's Business Daily
News headline image
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
News headline image
GE HealthCare Technologies Soars As GE Legacy Business Plummets
Wednesday marked the trading debut of GE HealthCare Technologies, the health-focused business spun off from General Electric. Shares rose 12%. 
Via MarketBeat
Topics Stocks
News headline image
What Does IDEXX Laboratories' Debt Look Like? ↗
Shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) moved higher by 28.56% in the past three months. Before having a look at the importance of debt, let's look at how much debt IDEXX Laboratories has. 
Via Benzinga
News headline image
3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023 ↗
By focusing on her interests, I hope to show my daughter that fascinating businesses are all around her. 
Via The Motley Fool
News headline image
Looking Into IDEXX Laboratories's Return On Capital Employed ↗
Pulled from Benzinga Pro data, IDEXX Laboratories (NASDAQ:IDXX) posted Q3 earnings of $180.94 million, an increase from Q2 of 37.1%. Sales dropped to $841.66 million, a 2.19% decrease between... 
Via Benzinga
News headline image
Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
News headline image
IDEXX Laboratories: Q3 Earnings Insights ↗
IDEXX Laboratories (NASDAQ:IDXX) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Peering Into IDEXX Laboratories's Recent Short Interest ↗
IDEXX Laboratories's (NASDAQ:IDXX) short percent of float has risen 14.54% since its last report. The company recently reported that it has 2.37 million shares sold short, which is 3.23% of all regular... 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years ↗
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 12.17% on an annualized basis producing an average annual return of 22.65%. Currently, IDEXX Laboratories has a... 
Via Benzinga
News headline image
Expert Ratings for IDEXX Laboratories ↗
Over the past 3 months, 7 analysts have published their opinion on IDEXX Laboratories (NASDAQ:IDXX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
News headline image
Don’t Miss the Turnaround in These 3 Stocks ↗
Of the 48 companies down more than double the S&P 500 year-to-date, these are the three stocks to buy for a turnaround in 2023. 
Via InvestorPlace
News headline image
Recap: IDEXX Laboratories Q2 Earnings ↗
  IDEXX Laboratories (NASDAQ:IDXX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $3,700 Today ↗
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 1.93% on an annualized basis producing an average annual return of 9.0%. Currently, IDEXX Laboratories has a... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.